TENUATE Drug Patent Profile
✉ Email this page to a colleague
When do Tenuate patents expire, and what generic alternatives are available?
Tenuate is a drug marketed by Sanofi Aventis Us and Nostrum Labs Inc and is included in four NDAs.
The generic ingredient in TENUATE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenuate
A generic version of TENUATE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENUATE?
- What are the global sales for TENUATE?
- What is Average Wholesale Price for TENUATE?
Summary for TENUATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 39 |
Patent Applications: | 643 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TENUATE at DailyMed |
![TENUATE drug patent expirations Drug patent expirations by year for TENUATE](/p/graph/s/t/TENUATE-patent-expirations.png)
US Patents and Regulatory Information for TENUATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017669-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | TENUATE DOSPAN | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012546-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | TENUATE | diethylpropion hydrochloride | TABLET;ORAL | 011722-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | TENUATE | diethylpropion hydrochloride | TABLET;ORAL | 017668-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |